ndomized Study of Didanosine Monotherapy and Combination Therapy With Zidovudine in Hemophilic and Nonhemophilic Subjects With Asymptomatic Human Immunodeficiency Virus-l Infection

@inproceedings{Ragni2002ndomizedSO,
  title={ndomized Study of Didanosine Monotherapy and Combination Therapy With Zidovudine in Hemophilic and Nonhemophilic Subjects With Asymptomatic Human Immunodeficiency Virus-l Infection},
  author={Margaret V Ragni and David A. Amato and Marsha L. LoFaro and Victor DeGruttola and C. van der Horst and M. Elaine Eyster and Craig Kessler and George F. Gjerset and Monto and David M. Parenti and Urania Dafni and Suraiya Rasheed and Joyce A. Korvick and Thomas C. Merigan},
  year={2002}
}
To evaluate the safety and efficacy of didanosine (ddl) monotherapy and three different combinations of zidovudine (ZDV) and ddl in asymptomatic human immunodeficiency virus-l (HIV-1) infection, we conducted an open-label, phase 1/11 study in 126 asymptomatic HIV-l-infected hemophilic and nonhemophilic subjects with a CD4 count of 200 to 500/mm3 stratified… CONTINUE READING